In an email to workers Wednesday night, the company said that since January it has had fewer than 10 cases of the virus that causes Covid-19 that were transmitted in the workplace
Here's a selection of Business Standard Opinion pieces for the day
Pandemic impact bottomed out in Q1, second half likely to see better growth
The streaming giant also said it has appointed Chief Content Officer Ted Sarandos as co-chief executive officer
Capgemini India's Chief Executive Officer Ashwin Yardi talks to Bibhu Ranjan Mishra and Sai Ishwar about the impact of Covid-19 on business
Indian private carriers will also be given an opportunity to fly on such long-haul routes, provided they operate wide-body aircraft for such flights
Southern states, where the growth was relatively slow, have increased their tally in a big way recently.
Most players that Business Standard spoke to said they would be concentrating on their own vaccine candidates or the current tie-ups that they have
The third of the five-part series looks at pick-up in metal sector demand & prices
Goyal raises totalisation issue during talks with Ross, also expresses concern over Indian exports being barred due to child labour issues
The fall in revenue and profit was broadly in line with other Main Street peers that have suffered from the need to brace for a deep recession
The company is undertaking similar steps for its employees in the UK and Australia
PSBs will need capital to finance economic revival
Consumer interest must be protected if travel maps are redrawn
Trading powerhouses Morgan Stanley and Goldman Sachs performed better than Main Street rivals JPMorgan Chase, Bank of America and Citigroup
The fourth phase of the Vande Bharat mission, which is currently underway, has been augmented with the addition of around 120 flights between July 15-31
Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and killer T-cells
Pre-tax profit of the bank in Q1FY21 stood at Rs 735 crore
With no new stock coming in, both patients and grey market vendors started running out of vigabatrin
First coronavirus vaccine to be tested in humans uses genetic material from a virus, called mRNA, to prompt the immune system to fight the disease